Delayed seropositivity is associated with lower levels of SARS-CoV-2 antibody levels in patients with mild to moderate COVID-19
Abstract Background Patients with COVID-19 can develop a range of immune responses, including variations in the onset and magnitude of antibody formation. The aim of this study was to investigate whether SARS-CoV-2 antibody levels vary in patients with mild to moderate COVID-19 in relation to the on...
Main Authors: | Marwa M. Fekry, Hanan Soliman, Mona H. Hashish, Heba S. Selim, Nermin A. Osman, Eman A. Omran |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-03-01
|
Series: | Journal of the Egyptian Public Health Association |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42506-023-00131-x |
Similar Items
-
Predictors of anti-SARS-CoV-2 seropositivity: An Egyptian population-based study
by: Engy Mohamed El-Ghitany, et al.
Published: (2022-06-01) -
COVID-19 Infection, Vaccination, and Antibody Levels: Investigating Correlations through a Cohort Study
by: Gözde Akkuş Kayalı, et al.
Published: (2023-07-01) -
Combination of rRT-PCR and Anti-Nucleocapsid/Anti-Spike Antibodies to Characterize Specimens with Very Low Viral SARs-CoV-2 Load: A Real-Life Experience
by: Zoe Florou, et al.
Published: (2021-06-01) -
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
by: Reka Varnai, et al.
Published: (2022-01-01) -
Comparison of SARS-CoV-2 seroprevalence estimates between commercial lab serum specimens and blood donor specimens, United States, September–December 2021
by: Szu-Yu Zoe Kao, et al.
Published: (2024-08-01)